Health Catalyst Announces $147 Million Divestiture of Vitalware
Health Catalyst has agreed to sell its mid-revenue cycle business, Vitalware, for $147 million in cash. The transaction is expected to strengthen the company's balance sheet and provide financial flexibility as it focuses on AI-driven core technology initiatives.
Topics: balance sheet strength divestiture strategic transformation